VE-822
CAS号 | 1232416-25-9 | 货号 | BCP07948 |
中文名 | VE-822 | ||
英文名 | VE-822 | ||
中文别名 | |||
英文别名 | VE822; VE 822; VX970; VX-970; VX 970; Berzosertib; | ||
分子式 | C24H25N5O3S | 分子量 | 463.55 |
生物活性 | VE-822, also known as VX-970 or Berzosertib, is an potent ATR inhibitor. VE-822 inhibited ATR in vitro and in vivo. VE-822 decreased maintenance of cell-cycle checkpoints, increased persistent DNA damage and decreased homologous recombination in irradiated cancer cells. VE-822 decreased survival of pancreatic cancer cells but not normal cells in response to XRT or gemcitabine. VE-822 markedly prolonged growth delay of pancreatic cancer xenografts after XRT and gemcitabine-based chemoradiation without augmenting normal cell or tissue toxicity. These findings support ATR inhibition as a promising new approach to improve the therapeutic ration of radiochemotherapy for patients with PDAC. | ||
信号通路 | Cell Cycle/DNA Damage PI3K/Akt/mTOR | ||
靶 点 | ATM/ATR |
结构式
本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服:
- 全国免费电话:400-099-8200
瀚香生物(Biochempartner) 的所有产品和服务仅用于科学研究,禁止用于人体和治疗!